The Effect of NovoMix 30, Levemir or NovoRapid (Alone or in Combination) in Subjects With Type 2 Diabetes Previously Treated With Other Anti-Diabetic Medication. A 24-Week, International, Prospective, Multi-Centre, Open-Labelled, Non-Interventional Study.
Phase of Trial: Phase IV
Latest Information Update: 23 Jan 2017
At a glance
- Drugs Insulin aspart (Primary) ; Insulin detemir (Primary) ; Insulin aspart/insulin protamine aspart
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Acronyms A1chieve
- Sponsors Novo Nordisk
- 10 Jun 2017 Biomarkers information updated
- 20 Apr 2011 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov.
- 20 Apr 2011 Actual end date reported as Dec 2010 by ClinicalTrials.gov.